Dislocation

Dislocation

Devon fell 43.0% from a $47.03 close on 31 July 2024 to $26.80 on 8 April 2025 — a real drawdown with a dated trigger, four sessions of tariff-and-OPEC+ selling. That episode has since closed. The stock recovered 65.7% off the low, traded above the old peak in March 2026, and sits at $44.41, 5.6% under the peak. Traded volume never confirmed capitulation: the measured spike was 1.92x.

The drawdown, quantified

Source: daily NYSE closing prices. Peak, trough, current and depth are the deterministic capitulation-gauge figures (peak $47.03 on 2024-07-31; trough $26.80 on 2025-04-08; current close $44.405 on 2026-07-29; depth −43.0%; 251 days peak-to-trough).

The fall took 251 days and arrived in three legs separated by two rallies, not one shock. On 634 million shares outstanding, the peak-to-trough move removed roughly $12.8 billion of equity value; what that figure should be measured against is the subject of Damage Math.

Source: daily NYSE closing prices, month-end closes; the 31 Jul 2024 peak ($47.03), 8 Apr 2025 trough ($26.80) and 27 Mar 2026 high ($52.07) are intramonth closes not shown by the month-end series.

Source: daily NYSE closing prices; leg endpoints are local closing extremes within the drawdown window.

Two qualifications on the current figure. The 29 July 2026 bar in the price feed carries 200 shares of volume against a $42.66 prior close, so it is an incomplete session print; the last full session, 28 July 2026, closed at $42.66 — 9.3% below the July 2024 peak rather than 5.6%. And the share count behind the deterministic feature file, 633 million, predates the Coterra merger that closed on 7 May 2026: Devon's own June 2026 deck sizes an $8 billion repurchase authorization at "15% of our market value" [1], implying a combined-company market value near $53 billion against the $28.1 billion the feature file carries. Per-share drawdown arithmetic is unaffected; anything divided by market cap is not, which matters in Yield.

The trigger

The event leg is four sessions, 3 to 8 April 2025, and Devon names the cause in its own filings. The Q1 2025 10-Q, covering the quarter that contained the crash, records that "during the first quarter of 2025, commodity prices have experienced heightened volatility and declines, driven primarily by economic uncertainty in global trade arising from geopolitical events and shifting trade policies, such as the imposition of tariffs by the U.S. and planned oil output increases by OPEC+" [2]. The FY2025 10-K repeats the attribution for the full year and adds the price move: WTI averaged $64.87 per barrel in 2025 against $75.79 in 2024, "an approximately 14% decline" [3].

The two dated external events sit on consecutive days. The US tariff schedule was announced after the close on 2 April 2025; on 3 April eight OPEC+ producers agreed to raise combined output by 411,000 barrels per day, roughly three times the increase the market expected for the following month. Devon's four sessions:

Source: daily NYSE closing prices and volume; multiples are against the 6.68 million-share median daily volume over the 180 calendar days before the 31 July 2024 peak — the same denominator the capitulation gauge uses.

Cumulatively the stock went from $37.92 on 2 April to $26.80 on 8 April, a 29.3% fall in four sessions on volume averaging 2.85x the pre-peak median. The reversal is as instructive as the fall: on 9 April, when the tariff schedule was paused for 90 days, Devon rose 15.9% in a single session — the largest up day in the entire window. Nothing Devon did caused either move.

The event leg versus the preceding slide. The first two legs took the stock from $47.03 to $30.52 between 31 July and 19 December 2024 — 35.1% — with no dated adverse company event attached. Devon reported Q2 2024 after the close on 6 August 2024, beating consensus EPS by 11.0%, and the stock rose 2.8% the next session; Q3 2024, reported after the close on 5 November 2024, came in 13.3% above consensus on revenue and in line on EPS, and the stock rose 1.7% the next session. The 9 December 2024 announcement that CEO Rick Muncrief would retire on 1 March 2025 was followed by a 1.5% gain. What fell over those five months was the crude price, carried into the equity. On the framework's own test — a fall with no dated event and no volume signature is a slide, not the moment — legs one and two are the slide and April 2025 is the moment.

The fear gauge

The measured spike is 1.92x: the highest 20-day average volume inside the peak-to-trough leg (12.79 million shares) divided by the median daily volume over the 180 calendar days before the peak (6.68 million shares). That is elevated, and it is a long way from capitulation.

Two features of where the spike sits matter more than its size. First, the 20-day window that produced the 1.92x maximum ended on 15 January 2025 — inside the December leg, roughly three months before the low. At the 8 April 2025 trough itself, the 20-day average had reached only 1.45x. Second, the single heaviest session of the whole fall, 20 December 2024 at 34.6 million shares or 5.19x the median, closed up 0.8%: that volume was mechanical, not selling pressure setting the price.

Source: daily NYSE traded volume; denominator is the 6.68 million-share median daily volume over the 180 calendar days before the 31 July 2024 peak.

The chart carries the finding. The heaviest sustained trading in this stock over the last thirty-one months was not the drawdown at all — it was March 2026 at 2.87x and May and June 2026 at 2.33x and 2.24x, the months around the Coterra merger vote and close. The fear months peaked at 1.82x (December 2024) and 1.71x (April 2025). April 2025 does show real intensity when read at daily resolution rather than on a 20-day average: 3.45x on 4 April, 2.65x on the trough day. The honest reading is that the smoothed gauge understates a four-session panic, and the panic was still not large by the standard of what this stock trades on merger news.

Who was selling

Short interest cannot be sourced from this run. Every field in the run's short-interest dataset returned zero rows — reported positions, borrow pressure, public net-short disclosures and peer context alike — so level and change are not measurable here. Publicly reported compilations of the semi-monthly FINRA reports put Devon's short interest at roughly 20.3 million shares (3.51% of float) in mid-December 2024, near 22.1 million shares (3.87%) in February 2025, back to roughly 16.4 million shares (2.88%) by late March 2025, and 16.65 million shares (2.95%, 2.01 days to cover) in December 2025. Those figures are third-party compilations with imprecise settlement dates, not primary data. On their face they describe a stock that was never crowded short and where the short base was shrinking before the April trough, not adding into it.

Insiders were absent from both sides. Across the 2,441 insider transactions in the corpus, exactly one open-market trade falls between 1 July 2024 and 31 July 2026: a 7,685-share sale at $33.46 on 11 August 2025. No Devon insider made an open-market purchase at any point during or after the 43% fall.

The two largest index holders did not sell. BlackRock reported 44,508,195 shares, 6.9% of the class, at 31 March 2025 — a week before the trough — and 49,513,335 shares, 7.9%, at 31 December 2025, an increase of five million shares. Vanguard reported 82,780,446 shares, 12.75%, at 31 March 2025; after its January 2026 internal realignment split the filing across two entities, the 31 March 2026 disclosures total 81,081,279 shares, 13.07% of a smaller class. Both positions rose as a share of the company through and after the fall.

The largest identified buyer was Devon. The company repurchased $1,057 million of stock in 2024 and $1,050 million in 2025, including $300 million in Q4 2024 and $301 million in Q1 2025 — the latter, on the CFO's account, "the upper end of our target buyback range for the quarter" [4]. Program-to-date, Devon has "repurchased approximately 100 million common shares for approximately $4.4 billion, or $44.02 per share" [5] — an average cost within a percent of today's price. What that says about the repurchase discipline belongs in Self-Help.

One structural supply event is on the record. The Grayson Mill Williston acquisition, closed 27 September 2024 for approximately $5.0 billion, was paid partly in "approximately 37.3 million shares of Devon common stock" [6] — about 5.9% of the share count, issued to a private seller in the middle of leg two. The filings disclose the issuance, not the disposition, so this is a supply fact rather than evidence of forced selling.

Nothing in this record identifies a forced or anchored seller of the kind the framework hunts. The visible holders held or added; the company bought; the shorts were small and shrinking. What sold was the marginal, unidentified holder of an oil-price proxy over four days.

Estimates versus price timing

The price fell substantially harder than the earnings, and it fell first.

Sources: share price from daily NYSE closes; core EPS from reported quarterly results; revenue and operating cash flow as reported; WTI averages from the FY2025 10-K [7].

Core EPS fell 19.0% between 2024 and 2025; the equity fell 43.0% peak to trough, 2.3 times as far. Operating cash flow did not fall at all — $6.7 billion in 2025 against $6.6 billion in 2024, which the 10-K attributes to "higher production volumes and lower taxes" offsetting lower oil prices [8].

The sequencing is the sharper point. Through the first 35% of the fall the company's own numbers were moving up, not down. Devon beat on Q3 2024 revenue by 13.3% and on Q4 2024 EPS by 15.7%. At the Q4 2024 call on 19 February 2025, with the stock 26% below its peak, management reported that "our board approved an increase to $0.24 per share… a 9% improvement over the 2024 rate" [9], and then raised 2025 guidance: "we're bumping our 2025 production and reducing our capital from the soft guide that we provided on the last call… We expect these improvements to drive more than $300 million in additional free cash flow this year" [10]. The stock rose 7.7% that day and then resumed falling.

The company's response to the April shock came after the shock, not before it: the business optimization plan targeting "$1.0 billion in annual pre-tax free cash flow improvements by the end of 2026" was announced in April 2025 [11], two weeks after the 8 April trough, and by the 6 May call had already been accelerated, with 2025 capital cut $100 million and the target framed as "deliver an additional $1 billion in annual free cash flow by year end 2026" [12]. The same call reported Q1 2025 operating cash flow of $1.9 billion, which "exceeded consensus estimates by a healthy margin" [13].

A limitation on the estimate side. The consensus revision feed available in this run holds only trailing-180-day snapshots taken from 30 January 2026 onward, so the analyst-estimate path across the 2024–25 fall cannot be measured directly; the comparison above uses reported results and company guidance instead. Where snapshots do exist, the 2026 pattern repeats: consensus FY2027 EPS was $5.478 on 29 June 2026 and $5.237 on 29 July 2026, a 4.4% cut, and FY2028 fell 2.1% over the same month — while the price had already fallen 22.7% from its 27 March 2026 high to its 1 July 2026 low. Snapshots from January and April 2026 are not comparable to these, because the Coterra merger re-based the estimate set (FY2027 consensus revenue moves from $15.8 billion to $26.6 billion across that boundary).

Where the price sits now

The 2024–25 dislocation has been repaired, and then some. From the $26.80 trough the stock returned 65.7% to $44.41, closed above the old $47.03 peak on 17 March 2026, and reached $52.07 on 27 March 2026 — 10.7% above the July 2024 high. It sits at the 61st percentile of its 52-week range of $31.74 to $52.57.

The decline since March 2026 is a commodity round trip rather than an adverse company event. Devon's Q1 2026 10-Q records that "during the first quarter of 2026, commodity prices have experienced heightened volatility, driven primarily by significant geopolitical events, including conflict in the Middle East and disruptions to global oil supply, along with continued uncertainty in global trade policy and OPEC+ production decisions," with WTI averaging roughly $72 in Q1 2026 against roughly $59 in Q4 2025, and a $0.6 billion non-cash derivative valuation loss reducing net earnings [14]. The stock rose with that spike and gave it back as it unwound: $52.07 on 27 March to $40.25 on 1 July, down 22.7%. The heaviest single session in the leg was 6 May 2026, down 8.6% on 39.8 million shares, the day after Q1 2026 results came in $0.05 below consensus EPS and 3.1% below on revenue — and the day before the Coterra merger closed. Against that, the company's June 2026 update reported a 33% dividend increase and the repurchase authorization upsized to $8 billion [15], with the current outlook "beating independent DVN + CTRA February original plans on production (+2%) with in-line capital" [16].

There is no live dislocation at $44.41. There was one — dated, triggered, and quantifiable — and it ended sixteen months ago. The stock trades 5.6% below its July 2024 peak, 65.7% above its April 2025 low, and within a percent of the $44.02 average price Devon itself has paid across 100 million shares of repurchases. The framework's entry condition asks for a stock that fear has repriced recently; the record shows a completed round trip instead, plus a second, shallower 22.7% commodity unwind since March 2026 that has already retraced 35% of its own decline. Whether what that leaves is cheap on adjusted cash flow is a separate question, answered in Yield, with the timing in Clock.